Barclays Maintains Overweight on Ormat Technologies, Lowers Price Target to $122
Barclays analyst David Anderson maintains Ormat Technologies (NYSE:ORA) with a Overweight and lowers the price target from $127 to $122.
Read original at benzingaStocks · News reference
Ormat Technologies Raises FY2026 Sales Guidance from $1.110B-$1.160B to $1.150B-$1.200B vs $1.170B Est
Ormat Technologies (NYSE:ORA) raises FY2026 sales outlook from $1.110 billion-$1.160 billion to $1.150 billion-$1.200 billion vs $1.170 billion estimate.
Reference details
Connected markets
Poisar stores the source's headline, summary and market tags for reference. Reporting and full article text remain with the original publisher.
- Source
- benzinga
- Observed
- Aug 5, 2026, 8:25 PM
- Checked
- Aug 5, 2026, 8:25 PM
- Cadence
- Captured once, then retained as an archive reference
- Status
- fresh
Keep reading
Related headlines
Oppenheimer Maintains Outperform on Ormat Technologies, Lowers Price Target to $141
Oppenheimer analyst Noah Kaye maintains Ormat Technologies (NYSE:ORA) with a Outperform and lowers the price target from $144 to $141.
Read original at benzingaOrmat Technologies shares are trading higher after the company reported better-than-expected Q2 financial results and raised its FY26 sales guidance.
Read original at benzinga8-K filing — ORMAT TECHNOLOGIES, INC. (ORA)
Filed: 2026-08-05 AccNo: 0001437749-26-025961 Size: 649 KB Item 2.02: Results of Operations and Financial Condition Item 9.01: Financial Statements and Exhibits
Read original at edgar